ICD-10 Coding for Celiac Panel Testing
The appropriate ICD-10 code for ordering a celiac panel depends on the clinical presentation: use K90.0 for suspected or confirmed celiac disease, Z71.3 for dietary counseling and surveillance in established disease, or symptom-specific codes (e.g., K59.1 for chronic diarrhea, D50.9 for iron deficiency anemia) when celiac disease is being ruled out as part of a differential diagnosis. 1
Primary ICD-10 Codes for Celiac Testing
For Suspected Celiac Disease
- K90.0 - Celiac disease (celiac sprue, gluten-sensitive enteropathy, nontropical sprue) is the most direct code when celiac disease is clinically suspected based on symptoms or risk factors 1
- This code is appropriate even before diagnostic confirmation, as it encompasses "suspected celiac disease" in clinical practice 2, 1
For Screening High-Risk Populations
- Z83.79 - Family history of other diseases of the digestive system, used when screening first-degree relatives of patients with celiac disease 1, 3
- E10.9 - Type 1 diabetes mellitus without complications, when screening diabetic patients for celiac disease 1, 3
- Q90.9 - Down syndrome, unspecified, when screening patients with Down syndrome 1, 4
For Symptom-Based Testing
- K59.1 - Chronic diarrhea, when evaluating unexplained chronic diarrhea 2, 1
- D50.9 - Iron deficiency anemia, unspecified, when celiac disease is present in 2-6% of patients with unexplained iron deficiency 1, 4
- R19.7 - Diarrhea, unspecified, for acute or subacute presentations 2
- R10.9 - Unspecified abdominal pain, when abdominal pain is the primary complaint 2
- R63.4 - Abnormal weight loss, for unexplained weight loss 2
- K90.9 - Intestinal malabsorption, unspecified, when malabsorption is suspected 2
Components of the Celiac Panel to Order
Initial Screening Tests
- IgA tissue transglutaminase antibody (tTG-IgA) is the single best serologic test with sensitivity of 90-96% and specificity >95% 2, 1, 4
- Total IgA level must be measured concurrently to rule out IgA deficiency, which occurs in 1-3% of celiac patients and causes falsely negative IgA-based tests 2, 1
Confirmatory and Supplemental Tests
- IgA endomysial antibody (EMA-IgA) should be performed when tTG-IgA is >10× upper limit of normal, as the combination approaches 100% positive predictive value 2, 1
- IgG deamidated gliadin peptide (DGP-IgG) or IgG tTG should be ordered if IgA deficiency is detected 2, 1
- IgG-based tests are markedly less accurate in patients with normal IgA levels and should not be used in that setting 1
Critical Testing Requirements
Patient Must Be on Gluten-Containing Diet
- Testing must be performed while the patient consumes at least 10g of gluten daily for 6-8 weeks 2, 1
- Reduction or avoidance of gluten prior to diagnostic testing reduces sensitivity of both serology and biopsy 2, 1
- Patients who have already started a gluten-free diet should resume normal diet with three slices of wheat bread daily for 1-3 months before repeat testing 2, 1
Biopsy Confirmation Required
- Intestinal biopsy remains the gold standard for diagnosis in adults, even with strongly positive serology 2, 1
- Multiple biopsy specimens (ideally 6 total: 1-2 from duodenal bulb and at least 4 from second part of duodenum) should be obtained 1, 3
- The exception is children with tTG-IgA ≥10× upper limit of normal, positive EMA-IgA, and positive HLA-DQ2/DQ8, who may avoid biopsy per recent pediatric guidelines 1
Additional Codes for Associated Conditions
When Screening for Complications
- M81.0 - Age-related osteoporosis without current pathological fracture, for premature osteoporosis screening 1, 4
- K74.60 - Unspecified cirrhosis of liver, for unexplained liver transaminase elevations 1, 4
- E03.9 - Hypothyroidism, unspecified, when screening for autoimmune thyroid disease 1, 4
Common Pitfalls to Avoid
Testing Errors
- Never rely solely on IgG tTG antibody in the absence of IgA deficiency, as it is not specific 2, 1
- IgA and IgG antigliadin antibodies (non-deamidated) confer no additional diagnostic benefit in adults and should not be ordered 2, 5
- Different tTG-IgA assays have varying sensitivity, so specify the threshold used (typically >10× upper limit of normal for high specificity) 2, 1
Documentation Requirements
- Document the clinical indication clearly in the medical record to support medical necessity 1
- Note whether the patient is on a gluten-containing diet at the time of testing 2, 1
- For screening high-risk populations, document the specific risk factor (family history, type 1 diabetes, etc.) 1, 3
Insurance Considerations
- Most insurers require documentation of symptoms, risk factors, or family history to approve celiac testing 1
- Using symptom-specific codes (diarrhea, anemia, weight loss) rather than screening codes may improve authorization rates when appropriate 1
- HLA-DQ2/DQ8 testing has limited diagnostic role and is primarily useful for its negative predictive value when celiac disease is strongly suspected despite negative serology 2, 1, 4